Off-label drug use in children and adolescents treated with antidepressants and antipsychotics: results from a prospective multicenter trial

The frequency of off-label use of antidepressants and even more of antipsychotics in youths treated at specialized child psychiatric centers is high. As the clinical efficacy and safety of off-label antidepressant and antipsychotic use in youth is under-researched, our results call for further pharmacovigilance studies and strategies to improve drug safety.

Authors

Institutions

Publication Details

Journal
Child and Adolescent Psychiatry and Mental Health
Published
2025-10-13
DOI
https://doi.org/10.1186/s13034-025-00957-7
Citations
3
Primary Topic
Pharmaceutical studies and practices
Type
article
Field-Weighted Citation Impact
10.48
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Off-label drug use in children and adolescents treated with antidepressants and antipsychotics: results from a prospective multicenter trial

Hartmut Imgart, Marcel Romanos, Michael Kaess, Paul L. Plener et al.
3 citations
Child and Adolescent Psychiatry and Mental Health
Pharmaceutical studies and practices
10.48
article

Off-label drug use in children and adolescents treated with antidepressants and antipsychotics: results from a prospective multicenter trial

Hartmut Imgart, Marcel Romanos, Michael Kaess, Paul L. Plener, Peter U. Heuschmann, Andreas Karwautz, Alexander Häge, Christian Rexroth, Su-Yin Reuter-Dang, Christoph Ulrich Correll, Gerd Schulte‐Körne, Karl Reitzle, Uwe Malzahn, Karin Egberts, Christian Fleischhaker, Tobias Hellenschmidt, Elvira Tini, Stefanie Fekete, Wolfgang Carl Briegel, Michael Kölch, Hans Rock, Regina Taurines, Tobias Renner, Maike Scherf‐Clavel, Christoph Wewetzer, Frank Theisen, Manfred Gerlach
article en
3 citations

Abstract

The frequency of off-label use of antidepressants and even more of antipsychotics in youths treated at specialized child psychiatric centers is high. As the clinical efficacy and safety of off-label antidepressant and antipsychotic use in youth is under-researched, our results call for further pharmacovigilance studies and strategies to improve drug safety.

Child and Adolescent Psychiatry and Mental HealthVol. 19(1)
University of Bern (CH), Philipps University of Marburg (DE), Zimmer Biomet (Netherlands) (NL), Bielefeld University (DE), Heidelberg University (DE), University of Würzburg (DE), University Medical Center Freiburg (DE), University Hospital Heidelberg (DE), University Hospital Regensburg (DE), German Center for Pediatric and Adolescent Rheumatology (DE), University Hospital of Zurich (CH), Central Institute of Mental Health (DE), Donald & Barbara Zucker School of Medicine at Hofstra/Northwell (US), Leopoldina Krankenhaus Schweinfurt (DE), Vivantes Klinikum (DE), German Center for Infection Research (DE), Klinik für Psychosomatik (DE), Universitätsklinikum Würzburg (DE), Social Neuroscience Lab (DE), German Centre for Cardiovascular Research (DE), Medizinische Hochschule Brandenburg Theodor Fontane (DE), University Hospital Cologne (DE), University Hospital Ulm (DE), Klinikum Fulda (DE), Zucker Hillside Hospital (US), University of Rostock (DE), Medical University of Vienna (AT), Charité - Universitätsmedizin Berlin (DE), University of Tübingen (DE), Ludwig-Maximilians-Universität München (DE)
Openalex Percentile: Top 2%
Pharmaceutical studies and practices
10.48
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.